At the end of the study, the frequencies of responders at both 30% (88%) and 50% (76%) were very high, with a reduction in pain intensity of about 5 points on a numerical scale from 0 to 10, which was highly significant both clinically and statistically.
← all excerpts
Tapentadol Prolonged Release Reduces the Severe Chronic Ischaemic Pain and Improves the Quality of Life in Patients with Type 2 Diabetes.
1
—
—